(Q41673673)

6 October 2017

Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study (English)

1 reference

6 October 2017

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

K Budde

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

F Lehner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

C Sommerer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

P Reinke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

W Arns

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

R P Wüthrich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

A Mühlfeld

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

K Heller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

M Porstner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

J Veit

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

E-M Paulus

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

O Witzke

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

ZEUS Study Investigators

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

17 December 2014

1 reference

American Journal of Transplantation

6 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

119-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection

11 June 2020

cites work

1 reference

Calcineurin inhibitors in kidney transplantation: friend or foe?

21 January 2018

1 reference

Cyclosporine withdrawal improves long-term graft survival in renal transplantation.

21 January 2018

1 reference

Calcineurin inhibitor minimization, withdrawal and avoidance protocols after kidney transplantation

21 January 2018

1 reference

De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.

21 January 2018

1 reference

Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus

21 January 2018

1 reference

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients

21 January 2018

1 reference

Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.

21 January 2018

1 reference

Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness

21 January 2018

1 reference

Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.

21 January 2018

1 reference

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

21 January 2018

1 reference

Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial

21 January 2018

1 reference

Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.

21 January 2018

1 reference

Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.

21 January 2018

1 reference

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

Assessing glomerular filtration rate by estimation equations in kidney transplant recipients

21 January 2018

1 reference

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

21 January 2018

1 reference

Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study.

21 January 2018

1 reference

mTOR inhibition: the learning curve in kidney transplantation

21 January 2018

1 reference

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study

21 January 2018

1 reference

Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation.

21 January 2018

1 reference

Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists

21 January 2018

1 reference

mTOR inhibitor-associated proteinuria in kidney transplant recipients

21 January 2018

1 reference

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

21 January 2018

1 reference

Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.

21 January 2018

1 reference

Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12952

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521535%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference